Interleukin 18-independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation

被引:130
作者
Gutcher, Ilona
Urich, Eduard
Wolter, Karina
Prinz, Marco
Becher, Burkhard [1 ]
机构
[1] Univ Zurich, Neuroimmunol Unit, Neurol Clin, CH-8057 Zurich, Switzerland
[2] Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany
关键词
D O I
10.1038/ni1377
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T helper type 1 (T(H)1) lymphocytes are considered to be the main pathogenic cell type responsible for organ-specific autoimmune inflammation. As interleukin 18 (IL-18) is a cofactor with IL-12 in promoting T(H)1 cell development, we examined the function of IL-18 and its receptor, IL-18R, in autoimmune central nervous system inflammation. Similar to IL-12-deficient mice, IL-18-deficient mice were susceptible to experimental autoimmune encephalomyelitis. In contrast, IL-18R alpha-deficient mice were resistant to experimental autoimmune encephalomyelitis, indicating involvement of an IL-18R alpha ligand other than IL-18 with encephalitogenic properties. Moreover, engagement of IL-18R alpha on antigen-presenting cells was required for the generation of pathogenic IL-17-producing T helper cells. Thus, IL-18 and T(H)1 cells are dispensable, whereas IL-18R alpha and IL-17-producing T helper cells are required, for autoimmune central nervous system inflammation.
引用
收藏
页码:946 / 953
页数:8
相关论文
共 52 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[3]   Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 [J].
Becher, B ;
Durell, BG ;
Noelle, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) :493-497
[4]   IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis [J].
Becher, B ;
Durell, BG ;
Noelle, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (08) :1186-1191
[5]   The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system [J].
Becher, B ;
Durell, BG ;
Miga, AV ;
Hickey, WF ;
Noelle, RJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) :967-974
[6]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[7]  
Boraschi Diana, 1998, European Cytokine Network, V9, P205
[8]   Immunopathogenesis of collagen arthritis [J].
Brand, DD ;
Kang, AH ;
Rosloniec, EF .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2003, 25 (01) :3-18
[9]   REGULATORY T-CELL CLONES INDUCED BY ORAL TOLERANCE - SUPPRESSION OF AUTOIMMUNE ENCEPHALOMYELITIS [J].
CHEN, YH ;
KUCHROO, VK ;
INOBE, J ;
HAFLER, DA ;
WEINER, HL .
SCIENCE, 1994, 265 (5176) :1237-1240
[10]   Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis [J].
Chu, CQ ;
Wittmer, S ;
Dalton, DK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :123-128